GLP-1 medications are not a trend. They are reshaping the health and aesthetics landscape for the long term. And that means the industry has to evolve with them. Patients will continue losing weight quickly. Clinics will continue seeing post-weight-loss concerns. The question is whether providers treat those concerns as isolated cosmetic complaints—or recognize them as signs of a deeper structural shift.